To The Moon

$MAIA Biotechnology Inc.(MAIA)$ has positive progress and shared a new report yesterday and following is summary. This is a prospectus supplement document from MAIA Biotechnology, Inc., related to the offering of up to $4,950,000 of common stock. It provides updated information supplementing the previous prospectus dated August 23, 2023. Key points include: 1. The offer of common stock is under Rule 415 of the Securities Act and involves certain limitations and provisions. 2. As of the date of the prospectus, the total public float of MAIA's common stock was approximately $34,903,391. 3. The highest closing price of the common stock prior to the date of the document was $2.11 per share. 4. A significant amount of common stock has been

U.S. stocks tumbled on the last trading day in January after the Federal Reserve held interest rates steady while dashing hopes for interest rate cut as soon as March.Regarding the options market, a total volume of 42,925,172 contracts was traded on Wednesday.Top 10 Option VolumesTop 10: $SPY(SPY)$; $QQQ(QQQ)$; $SPX(SPX)$; $TSLA(TSLA)$; $IWM(IWM)$; $AMD(AMD)$; $NVDA(NVDA)$; $MSFT(MSFT)$; $HYG(HYG)$;

$Technology Select Sector SPDR Fund(XLK)$ The technology sector has been doing well towards the end of 2023. With this in mind, I decided to sell put $XLK 20240119 184.0 PUT$ on 15 December 2023. XLK Daily Chart The pullback during the first week of 2024 definitely seems scary. However, I wanted to wait for the interaction at 184 support level, and luckily, the price bounced back without fail. I decided to take a profit and close the trade on 11 January to free up money for newer trades. XLK Put Chart At some point, my trade was down over 100%, which again I would like to emphasize that if you do not have the risk appetite, do not try to trade options as it can be very volatile!